Sage Therapeutics Inc
SAGE
Market Cap$788.69M
Close$
$21.43
61.8% upside
Current Fair Value
61.8% upsideUndervalued by 61.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $788.69 Million |
|---|---|
| Enterprise Value | $71.67 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-8.39 |
| Beta | 0.76 |
| Outstanding Shares | 60,182,031 |
| Avg 30 Day Volume | 1,278,139 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.57 |
|---|---|
| PEG | 6.0 |
| Price to Sales | 13.25 |
| Price to Book Ratio | 1.2 |
| Enterprise Value to Revenue | 0.79 |
| Enterprise Value to EBIT | -0.14 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Sage Therapeutics Inc
CEO: Jeffrey Jonas